Lymphocyte subsets (CD69) LIS Code: CD69
Assess immune activation with CD69 lymphocyte subset testing. Accurate private immunology testing.
Test Categories
About this test
Overview of Lymphocyte Subsets (CD69) Test
The Lymphocyte Subsets (CD69) Test measures CD69+ lymphocytes, an early activation marker found on T-cells, B-cells, and natural killer (NK) cells. CD69 plays a vital role in initiating immune responses and provides important information about immune system activity.
Importance of CD69 Testing
CD69 is one of the earliest indicators of immune activation. Abnormal levels may reflect immune system overactivity, chronic infections, or suppressed immunity, making this test valuable for diagnosing and managing immune-related conditions.
Who Should Consider This Test
Patients with autoimmune disorders such as lupus, rheumatoid arthritis, or multiple sclerosis
Individuals with chronic infections like Epstein-Barr virus (EBV) or HIV
Cancer patients, especially those with leukemia, lymphoma, or tumor-associated immune activity
People experiencing chronic fatigue, fibromyalgia, or persistent inflammation
Transplant recipients to monitor for early signs of rejection or immune suppression
What the Test Can Reveal
Immune Activation: Elevated CD69 levels may indicate an active immune response due to infection or autoimmune disease
Chronic Inflammation: Ongoing immune activity may suggest long-term inflammatory conditions
Immune Suppression: Low CD69 levels could signal immune deficiency or reduced immune function
Clinical Significance
The CD69 test is a critical tool in immunological evaluation. It supports early detection and monitoring of immune-related disorders, enabling timely and effective treatment interventions.
